JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

Monsters are real

JDRF Canada has a plan to defeat the T1D monster that burdens 300,000 Canadians.

Read More

Ustekinumab, A Potentially Disease Modifying Drug for Type 1 Diabetes, Is Being Tested in Clinical Trials in Canada

Ustekinumab, A Potentially Disease Modifying Drug for Type 1 Diabetes, Is Being Tested in Clinical Trials in Canada

A JDRF-funded clinical trial is examining whether a drug currently (ustekinumab; pronounced oos·teh·KIN·yoo·mab) used for the treatment of psoriasis (which affects the skin), Crohn’s disease (an inflammatory bowel disease), and other autoimmune conditions can also w...


JDRF Advocacy Efforts to Ensure COVID-19 Vaccination Priority for the Type 1 Diabetes Community

JDRF Advocacy Efforts to Ensure COVID-19 Vaccination Priority for the Type 1 Diabetes Community

We’ve received many questions about the COVID-19 vaccination rollout in provinces and territories across Canada, and specifically at what stage people living with type 1 diabetes (T1D) should expect to receive theirs.


Exciting new updates in JDRF funded research of Sernova's Cell Pouch System

Exciting new updates in JDRF funded research of Sernova's Cell Pouch System

On January 15, 2021 Sernova announced that patients in their ongoing clinical trial show persistent islet function and clinically meaningful improvement in glucose control.


JDRF Canada recognizes #BellLetsTalk

JDRF Canada recognizes #BellLetsTalk

January 28, 2021 marks this year’s #BellLetsTalk day. This provides us the opportunity to talk freely and safely about mental health issues, and to raise awareness of the challenges faced by people living with T1D daily – and how JDRF Canada is looking to do more to address mental health...


Simplifying insulin management and delivery

Simplifying Insulin Management and Delivery

For years, Rebecca Redmond’s mantra was to “stick to the devil you know” when managing her type 1 diabetes (T1D). That meant injecting herself with insulin numerous times a day, even after developing a phobia of needles, resulting in debilitating anxiety attacks and sometimes even ...


Your fundraising dollars at work

Your fundraising dollars at work

Here are the top 2020 JDRF-funded research projects.


New Drug to Prevent Hypoglycemia Enters Clinical Trials

New Drug to Prevent Hypoglycemia Enters Clinical Trials

Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue treatments for it, such as injectable or nasal glucagon (Baqsimi), there are currently no preventive therapies available. Canadian company Zucara Therapeutics, however, may...


COVID-19 and type 1 diabetes - What we know now

COVID-19 and type 1 diabetes - What we know now

Protecting yourself from the virus on top of everyday diabetes management is a lot to deal with. Fortunately, we are now better equipped with knowledge of how the virus works and how to best protext ourselves from contracting it. And there is hope on the horizon.


COVID-19 Vaccines and T1D

COVID-19 Vaccines and T1D

JDRF welcomes the authorization of the first COVID-19 vaccine by Health Canada, which we hope will be one of many to be approved in the coming months to address the pandemic. We are grateful for the unprecedented effort by  the many research scientists, clinical trial participants, in...


Lets turn type one into type none